tiprankstipranks
Minerva Neurosciences (NERV)
NASDAQ:NERV
US Market

Minerva Neurosciences (NERV) Financial Statements

Compare
614 Followers

Minerva Neurosciences Financial Overview

Minerva Neurosciences's market cap is currently $267.44M. The company's EPS TTM is $-0.64; its P/E ratio is -0.04; Minerva Neurosciences is scheduled to report earnings on March 11, 2026, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -5.44K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -15.10M$ -21.85M$ -23.12M$ -25.23M$ -45.37M
EBITDA$ -15.10M$ 6.02M$ -21.69M$ -24.69M$ -45.28M
Net Income$ -293.42M$ 1.44M$ -30.01M$ -32.11M$ -49.91M
Balance Sheet
Cash & Short-Term Investments$ 82.30M$ 21.36M$ 40.91M$ 36.09M$ 60.76M
Total Assets$ 97.97M$ 37.14M$ 56.90M$ 55.09M$ 77.12M
Total Debt$ 64.96M$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -17.34M$ -21.36M$ -40.91M$ -36.09M$ -60.76M
Total Liabilities$ 238.72M$ 62.84M$ 85.36M$ 75.11M$ 69.15M
Stockholders' Equity$ -140.75M$ -25.69M$ -28.46M$ -20.02M$ 7.98M
Cash Flow
Free Cash Flow$ -13.51B$ -19.55M$ -14.78M$ -24.66M$ -24.60M
Operating Cash Flow$ -13.51B$ -19.55M$ -14.78M$ -24.65M$ -24.60M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ -16.33K$ 0.00
Financing Cash Flow$ 74.45B$ 0.00$ 19.60M$ -5.00$ 60.00M
Currency in USD

Minerva Neurosciences Earnings and Revenue History

Minerva Neurosciences Debt to Assets

Minerva Neurosciences Cash Flow

Minerva Neurosciences Forecast EPS vs Actual EPS